Form 4: Mural Oncology Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Maiken Keson-Brookes, Chief Legal Officer and Secretary of Mural Oncology, sold 2,157 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On July 18, 2024, Maiken Keson-Brookes, Chief Legal Officer and Secretary of Mural Oncology plc, sold 2,157 ordinary shares of the company.
- The shares were sold at a price of $3.41 per share.
- This transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on December 14, 2023.
- The sale was conducted automatically under a pre-arranged plan (Rule 10b5-1) established on December 22, 2023.
- Following the transaction, Keson-Brookes beneficially owns 43,850 shares, including 38,705 unvested restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the officer's confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The sale of shares by an officer could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 2023-12-14 | Date of grant of restricted stock units to the Reporting Person. |
| 2023-12-22 | Date of entry into a Rule 10b5-1 plan. |
| 2024-07-18 | Date of the share sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.